Otofarma SpA (MIL:OTO) Other Current Receivables: €0.00 Mil (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Other Current Receivables?

Otofarma SpA MIL:OTO 16 Other Current Receivables is €0.00 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Other Current Receivables for the quarter that ended in Dec. 2024 was €0.00 Mil.

Otofarma SpA Other Current Receivables Related Terms

Otofarma SpA Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Other Current Receivables Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Other Current Receivables
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Other Current Receivables 0.00 0.00
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €0.00 Mil mean?
Otofarma SpA (MIL:OTO) has a Other Current Receivables of €0.00 Mil as of Dec. 2024. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Other Current Receivables too high?
Otofarma SpA's current Other Current Receivables is €0.00 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Other Current Receivables compare to ABT and SYK?
Otofarma SpA's Other Current Receivables of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Other Current Receivables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Other Current Receivables of €0.00 Mil. The current Other Current Receivables is €0.00 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Other Current Receivables is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price